2012 Archive


Steven Gillis, Ph.D., Managing Director of ARCH Venture Partners, Named Chairman of the Board; Michael Steinmetz, Ph.D., of Clarus Ventures to Join Board ANN ARBOR, Mich. – February 15, 2012 – Lycera Corp., a biopharmaceutical company pioneering innovative approaches to developing novel oral medicines to treat autoimmune diseases, today announced that Steven Gillis, Ph.D., managing… Read More

ANN ARBOR, Mich. – January 31, 2012 – Lycera Corp., a biopharmaceutical company pioneering innovative approaches to developing novel oral medicines to treat autoimmune diseases, today announced that the company will present at the following industry conferences. World Cancer Metabolism Summit, being held Feb. 1-2 at the Washington Marriott Hotel in Washington, D.C. Gary D.… Read More